4.5 Article

Protective role of silent information regulator 1 against hepatic ischemia: effects on oxidative stress injury, inflammatory response, and MAPKs

Journal

EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 20, Issue 5, Pages 519-531

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2016.1153067

Keywords

oxidative stress injury; inflammatory response; mitogen-activated protein kinases; Silent information regulator 1; hepatic ischemia reperfusion injury

Funding

  1. China Postdoctoral Science Foundation [2015M572681]
  2. National Natural Science Foundation of China [81500263, 81570231, 81422004, 81470480, 81470477, 81100137, 81100081]
  3. National High-tech R&D Program of China [2014AA020514, 2015AA020919]
  4. Technological New Star Program of Shaanxi Province [2014KJXX-56]

Ask authors/readers for more resources

Objective: Previous studies have verified that silent information regulator 1 (SIRT1), a class III histone deacetylase, protects against ischemia reperfusion (IR) injury (IRI) in some organs. In this study, we examined whether SIRT1 could protect against hepatic IRI and explored the potential mechanisms. Research design and methods: We examined whether SIRT1 could protect against hepatic IRI in vivo and in vitro using hepatic-specific SIRT1(-/-) mice, SIRT1 siRNA-transfected hepatocytes and SIRT1(+/+) hepatocytes. Results: The expression and activity of SIRT1 were significantly reduced during reperfusion compared with that observed in the control group. Hepatic-specific SIRT1(-/-) mice exhibited significant increase of hepatic damage markers and augment of oxidative stress and inflammatory response compared with control mice. In vitro studies demonstrated similar results. Furthermore, SIRT1 upregulation protects against hepatic IRI, through the overexpression of p-JNK, p-p38MAPK, and p-ERK. The protection of SIRT1 can be effectively reversed by the inhibitors of p38MAPK, JNK, and ERK. Conclusion: The activation of SIRT1 significantly inhibits the oxidative stress and inflammatory response during hepatic IRI, which can be developed as a novel method to protect against hepatic IRI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available